Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ACHILLES THERAPEUTICS PLC

Company number 13027460

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
03 Feb 2021 SH10 Particulars of variation of rights attached to shares
03 Feb 2021 SH10 Particulars of variation of rights attached to shares
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
03 Feb 2021 SH08 Change of share class name or designation
28 Jan 2021 PSC07 Cessation of Iraj Leo Kiryakos Keverian Ali as a person with significant control on 11 December 2020
28 Jan 2021 PSC02 Notification of Syncona Limited as a person with significant control on 11 December 2020
23 Dec 2020 TM01 Termination of appointment of Karl Peggs as a director on 22 December 2020
22 Dec 2020 SH20 Statement by Directors
22 Dec 2020 SH19 Statement of capital on 22 December 2020
  • GBP 123,414.398
22 Dec 2020 CAP-SS Solvency Statement dated 14/12/20
22 Dec 2020 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
18 Dec 2020 SH01 Statement of capital following an allotment of shares on 11 December 2020
  • GBP 148,097,277.6
18 Dec 2020 AP01 Appointment of Mr Martin Murphy as a director on 11 December 2020
18 Dec 2020 AP01 Appointment of Edwin Moses as a director on 11 December 2020
18 Dec 2020 SH10 Particulars of variation of rights attached to shares
18 Dec 2020 SH08 Change of share class name or designation
18 Dec 2020 MA Memorandum and Articles of Association
18 Dec 2020 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Shareholder consent; omnibus plan approved; tx plan reserve confirmed 11/12/2020
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
17 Dec 2020 AP01 Appointment of Carsten Boess as a director on 11 December 2020